Drug Type Monoclonal antibody |
Synonyms LOCK-CTLA4 |
Target |
Mechanism CTLA4 inhibitors(Cytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), T lymphocytes stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization PrecisemAb Biotech Co., LtdStartup |
Active Organization- |
Inactive Organization PrecisemAb Biotech Co., LtdStartup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoma | Preclinical | TW | PrecisemAb Biotech Co., LtdStartup | - |